For 15 years, we at Reflow Medical have been building, learning, advancing, and continuously challenging what is possible in cardiovascular care. This anniversary is an important milestone for us and…
Read More
San Clemente, CA – May 20, 2026 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the presentation of the first six-month clinical…
Read More
LINC 2026: Mainstage Symposium and Live Case Insights
Read More
San Clemente, CA – April 23, 2026 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, today announced the U.S. market launch of…
Read More
San Clemente, CA – April 13, 2026 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announces that12-month results from the DEEPER…
Read More
San Clemente, CA – September 29, 2025 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the completion of enrollment in the DEEPER…
Read More
In the past 12 months, we’ve signed 25 new distribution agreements with strong, strategic partners located outside of the U.S. who understand our mission and are ready to amplify it.…
Read More
San Clemente, CA – May 29, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug…
Read More
San Clemente, CA – March 6, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary…
Read More
On November 5, 2024, the VIVA Foundation reported on presentations at the VIVA25 conference, including two-year results of the DEEPER OUS clinical trial for the Reflow Medical Spur® Peripheral Retrievable…
Read More
Recent Comments